Purpose: We examined how mental health measures, sleep and physical function are associated with the presence and type of urinary incontinence and severity in women seeking treatment for lower urinary tract symptoms. Materials and Methods: This baseline cross-sectional analysis was performed in treatment seeking women with lower urinary tract symptoms. All participants completed the LUTS (Lower Urinary Tract Symptoms) Tool (Pfizer, New York, New York), which was used to classify women based on urinary incontinence symptoms and measure severity. The PROMIS (Patient-Reported Outcomes Measurement Information System) questionnaire for depression, anxiety, sleep disturbance and physical function, the PSS (Perceived Stress Scale) and the IPAQ-SF (International Physical Activity Questionnaire Short Form) were administered. Multivariable regression modeling was done to assess associations with urinary symptom presence, type and severity. Results: We studied 510 women with a mean AE SD age of 56 AE 14 years. Of the women 82% were Caucasian, 47% were obese and 14% reported diabetes. Urinary incontinence was reported by 420 women (82.4%), including stress urinary incontinence in 70, urgency urinary incontinence in 85, mixed urinary incontinence in 240 and other urinary incontinence in 25. On adjusted analyses there was no difference in any mental health, sleep or physical function measure based Accepted for publication April 27, 2018. No direct or indirect commercial incentive associated with publishing this article. The corresponding author certifies that, when applicable, a statement(s) has been included in the manuscript documenting institutional review board, ethics committee or ethical review board study approval; principles of Helsinki Declaration were followed in lieu of formal ethics committee approval; institutional animal care and use committee approval; all human subjects provided written informed consent with guarantees of confidentiality; IRB approved protocol number; animal approved project number.
on the presence vs the absence of urinary incontinence. Among women with urinary incontinence PROMIS anxiety and sleep disturbance scores were higher in those with mixed urinary incontinence than stress urinary incontinence. Increasing urinary incontinence severity was associated with higher PROMIS depression and anxiety scores, and higher PSS scores. However, higher urinary incontinence severity was not associated with a difference in sleep or physical function. Conclusions: Among treatment seeking women with lower urinary tract symptoms, increasing urinary incontinence severity rather than the presence or type of urinary incontinence was associated with increased depression, anxiety and stress.
Key Words: urinary bladder, urinary incontinence, patient reported outcome measures, depression, anxiety LOWER urinary tract symptoms are common and negatively impact quality of life. 1 Of the various LUTS UI is highly prevalent in women 2, 3 and it is often associated with depression, anxiety, sleep disturbances and poorer physical function. 4e8 However, prior research has been performed in community based populations or was ascertained from single institution studies. In treatment seeking patients it is not clear whether LUTS alone, the presence of UI or certain types of UI are associated with disturbances in mental health, sleep and physical function.
The LURN was created to address gaps in LUTS understanding. 9 As part of this effort the LURN clinical sites recruited treatment seeking patients in an observational cohort, from which data and validated questionnaires were collected. We hypothesized that women who reported UI would experience greater impairment in mental health, sleep and physical function measures than women with LUTS but without UI. We also hypothesized that women with UUI or MUI would have greater depression, anxiety, stress and sleep disturbance as well as poorer physical function than women with SUI symptoms and these differences would become greater as UI severity increased.
The objectives of this study were to examine whether mental health, sleep and physical function were associated with the presence and type of UI and with UI severity in women seeking treatment for LUTS.
MATERIALS AND METHODS
The LURN consists of 6 research sites and a data coordinating center. Participants in this network are performing a prospective observational study (ClinicalTrials.gov NCT02485808). Details of recruitment, and inclusion and exclusion criteria were published previously. 2 The observational cohort study was approved by the institutional review board at each site and all participants provided informed consent prior to enrollment. We performed a cross-sectional analysis of baseline information from women seeking treatment for LUTS who enrolled in the LURN observational cohort. As specified for this cohort women with urological pain (eg interstitial cystitis) were excluded from analysis.
All participants completed baseline questionnaires to assess medical history and demographic information as well as a series of validated questionnaires assessing pelvic floor symptoms, LUTS severity, mental health, sleep and physical function measures. The LUTS Tool, version 1 is a validated measure including 22 questions that assess severity and bother for a range of urinary symptoms. 10 This tool was used to categorize women with LUTS into subgroups based on the presence and the type of UI (SUI, UUI, MUI and other UI). Question 16 of the LUTS Tool states, "Below are several situations in which people can leak urine. How often in the past week have you." followed by 7 subitems (a to g) specifying different leakage triggers. Women who responded affirmatively with sometimes, often or almost always to any question 16 subitem (a to g) were categorized in the group with UI. Those who responded with never or rarely to all 7 subitems were categorized into the group without UI.
Those with UI were further categorized into groups based on UI type. Women who responded affirmatively to items c or d (leakage with laughing, sneezing, coughing or physical activity) were considered to have SUI. Affirmative responses to item b (leakage with a sudden need to rush to urinate) were considered to have UUI. Affirmative responses to a combination of item b and c or d were considered to indicate MUI. The 25 women who only responded affirmatively to any of the other UI items (leakage with sleeping, sexual activity, post-void or for no reason) were considered to have other UI and were not further analyzed as a UI subgroup.
Finally we calculated a continuous incontinence severity measure using the 7 LUTS Tool subitems related to incontinence (question 16, a to g). For this severity measure we converted the 7 subitems to distance measures and calculated a weighted Euclidean length with high numbers indicating more severe symptoms. Details and validation of this UI severity measure were previously published. 11 We created UI severity scores for all participants, including those in the other UI subgroup.
Participants also completed several short form measures, including the PROMIS questionnaires for sleep disturbance, depression, anxiety and physical function 12e14 as well as the PSS 15 and the IPAQ-SF. 16 PROMIS raw scores were converted into t scores using the recommended scoring methodology. 17 The t score rescales raw scores into standardized scores on a range of 0 to 100 with a mean AE SD of 50 AE 10. Higher PROMIS t scores indicate higher levels of the health concept. For example, higher sleep disturbance scores signify more sleep disturbance while higher physical function scores indicate better physical function. For PROMIS t scores the minimal clinically important difference is generally considered to be a 3 to 5-point difference or medium effect size. 18 We used the IPAQ-SF to assess physical activity. This scale assesses 3 types of physical activity, including walking, and moderate intensity and vigorous activities. The duration in minutes and the frequency of these various activities are incorporated into the score with a higher score indicating more physical activity. Scores can also be categorized into overall low, moderate and high activity groups.
The PSS uses a Likert scale to score 10 questions on feelings of stress in the prior month. PSS scores can range from 0 to 40 with higher scores indicating more stress.
Baseline demographic and medical history variables were assessed in all patients. The FCI 19 was administered and served as an overall comorbidity indicator. The CTES 20 was also administered. The CTES inquires about 6 areas of potential childhood trauma, ranging from major upheaval between parents such as divorce and separation to traumatic sexual experiences. Because there are no widely accepted conventions for how to use CTES scores, we assessed for the proportion of women who answered yes to any question. We also separately assessed for the report of a childhood traumatic sexual experience.
Demographic and clinical characteristics were evaluated by the chi-square test and nonparametric ANOVA. On unadjusted analyses differences in mean outcome measure scores by group, including with vs without UI and UI type (SUI vs UUI vs MUI), were assessed with parametric and nonparametric ANOVA using the Kruskal-Wallis and Wilcoxon post hoc tests or the chisquare test as appropriate. All baseline demographic, medical history, FCI and CTES variables along with UI presence, type and severity were considered candidate predictors in multivariable regression modeling.
The selection of covariates for the final models of each outcome was guided by the best subsets method. 21 For each outcome 3 models were fitted using UI presence, type and severity, respectively, as the primary predictor with relevant adjustment covariates. Multivariable linear regression was done on all outcomes except the IPAQ-SF, for which multivariable logistic regression was used. All p values were adjusted for multiple testing to control the FDR using the method proposed by Benjamini and Hochberg. 22 All statistical tests were done with SASÒ, version 9.4 with p <0.05 considered statistically significant.
RESULTS
Of the 545 women enrolled in the LURN observational cohort study 510 provided complete responses to question 16 of the LUTS Tool and comprised our study population. Figure 1 shows the results of all adjusted analyses based on UI presence.
In the 420 women with UI we next considered whether there were differences in mental health, sleep or physical function based on UI type. Using the LUTS Tool for categorization 70 women had SUI, 85 had UUI and 240 had MUI. As mentioned, the 25 women with other UI alone were excluded from this portion of the analysis. In our study population women with SUI compared to those with UUI or MUI were younger (mean age 53.0 AE 13.4 years) and had a lower BMI (43% with BMI less than 25 kg/m 2 ), less sleep apnea (6%) and a lower mean FCI (1.9 AE 1.8) than the other 2 UI subgroups, particularly when they were compared with the MUI group (supplementary table, http://jurology.com/). On unadjusted analyses women with MUI reported the highest depression (mean score 54.2 AE 8.7), anxiety (mean score 51.8 AE 9.5) and Figure 1 . Forest plot of differences in mental health, sleep and physical function measures in women with vs without UI. Those without UI still reported bothersome LUTS. Adjusted mean group differences from PSS and PROMIS short form questionnaires were obtained from linear regression models. IPAQ-SF adjusted OR was modeled by logistic regression. Physical function scale was reversed to be consistent with other outcomes. Figure 2 shows the results of adjusted analyses of all outcomes based on UI subtype. Finally we assessed mental health, sleep and physical function based on UI severity. As noted, UI severity scores were calculated using the results of all LUTS Tool UI items regardless of UI category. Thus, we were able to create an individual UI severity score for each study participant. UI severity scores ranged from 0 to 9.44 and mean scores were highest in women with MUI compared to those with SUI and UUI (5.39 AE 1.54 vs 3.98 AE 1.48 and 3.31 AE 1.13, respectively) and other UI (each p <0.001, fig. 3 ). In linear regression models using UI severity as a predictor of various outcome measures while adjusting for relevant covariates, increasing UI severity was associated with higher PROMIS depression 3 and fig. 4 ).
DISCUSSION
We report our findings in a large cohort of treatment seeking women with LUTS. Contrary to our hypothesis and previous reports in the literature in these women the dichotomous presence or absence of UI was not independently associated with differences in mental health, sleep or physical function. However, higher UI severity regardless of type was associated with increased anxiety, depression and stress. UI severity was not an independent predictor of sleep disturbance or physical function in this population of treatment seeking women who reported bothersome LUTS.
Our findings differ from some of those previously reported. We only studied women seeking treatment for LUTS and did not compare them to a healthy control population without LUTS. Two recent population based studies from Korea 23 and Ireland 24 included approximately 7,000 participants each and showed that depression was higher in adults with UI than in those without UI. In these studies adults without UI may have more closely resembled a healthy control population while in our study those without UI still had other bothersome LUTS.
Other groups have studied mental health factors in adults seeking treatment for OAB.
5e7 Together these studies showed that OAB was associated with higher anxiety, depression and sleep disturbance compared to controls. Again the comparison groups in these studies were control participants without LUTS. Also in these studies sample size precluded rigorous multivariable analyses with adjustment for potential confounders.
On our analysis adjustments for medical comorbidities (ie FCI) and the presence of diabetes were particularly important. These covariates were highly prevalent in our study population and in most models adjustment for these covariates removed the significance that was seen in unadjusted results. Age, education and sleep apnea were additional covariates that led to changes in significance in some models.
Despite the differences our findings with regard to UI severity are quite consistent with prior publications. In the Korean study by Lim et al, 23 the American studies by Ge 5 and Lai 6,7 et al, and a similar Brazilian study by Melotti et al 25 UI severity positively correlated with anxiety, depression and stress measures even when different outcome measures were used. The consistency of these results improve the credibility of our finding that worsening UI severity is an important factor associated with mental health.
In women who reported UI in our study UI severity scores ranged from 1.84 to 9.44. Based on our modeling results there was a 3.8 to 4.8 point margin of difference in PROMIS depression and anxiety scores in women with the lowest vs the highest UI severity scores. This is considered a midsized difference in PROMIS t scores, which may be clinically relevant. 18 Thus, our findings show that higher UI severity is associated with higher anxiety and depression, although how this impacts clinical care requires further study.
Regarding the PSS, our modeling results suggest that there could be a 3-point higher PSS score in women with high UI severity than in those with no UI. Unfortunately to our knowledge there are no Figure 3 . UI severity by subtype was calculated as weighted Euclidean distance (square root of sum of squared responses) of 7 LUTS Tool incontinence questions. Weights were calculated using ratio of average correlation of given question to average total correlation of all 7 questions to account for potential question redundancy. published data on minimal clinically important differences for the PSS. For a scale that ranges between 0 and 40 points the clinical relevance of these findings require further study. Strengths of the study include the large sample size with a geographically varied cohort. Data were collected using high quality validated tools for UI and quality of life. We included multiple covariates in our analyses to account for possible confounding factors. A novel analytical method incorporating the Euclidean length principle 11 was applied to determine UI severity using the LUTS Tool. This method is a useful contribution since it incorporates responses from all questions rather than only those that fall into predetermined clinical definitions of incontinence types. Thus, we were likely to achieve a more comprehensive understanding of how global UI severity is associated with mental health compared to the information that we could gather using single item ratings.
Our study is limited by multiple factors. The study population was predominantly Caucasian and lacked racial and ethnic diversity. Participants were seeking care at tertiary medical centers and, thus, may not be representative of the general population. We did not control for the influence of the perception of general health on our outcomes of interest and we lacked a healthy control group for comparison. An additional limitation is that our definitions may have resulted in misclassifying some women with mild or minimal UI into the without UI group. Finally, we performed many statistical comparisons, which increased the risk of false-positive results. However, we included FDR adjustments for all analyses to reduce the risk of type I errors.
CONCLUSIONS
We evaluated associations between UI and multiple measures among treatment seeking women with LUTS. Women with SUI, UUI or MUI did not demonstrate clinically important differences in mental health, sleep or physical function. However, higher UI severity was associated with higher depression, anxiety and perceived stress regardless of the type of UI.
